These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 984786)

  • 1. Comparative pharmacology of josamycin and erythromycin stearate.
    Strausbaugh LJ; Bolton WK; Dilworth JA; Guerrant RL; Sande MA
    Antimicrob Agents Chemother; 1976 Sep; 10(3):450-6. PubMed ID: 984786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The pharmacokinetics of josamycin].
    Wildfeuer A; Lemme JD
    Arzneimittelforschung; 1985; 35(3):639-43. PubMed ID: 4039591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of two erythromycin esters in plasma and in saliva following oral administration in humans.
    Ducci M; Scalori V; del Tacca M; Soldani G; Bernardini C; Grothe E; Bertelli A
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):494-7. PubMed ID: 7298242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and tolerance of erythromycin and josamycin in the prevention of bacteraemia following dental extraction.
    Sefton AM; Maskell JP; Kerawala C; Cannell H; Seymour A; Sun ZM; Williams JD
    J Antimicrob Chemother; 1990 Jun; 25(6):975-84. PubMed ID: 2196261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of macrolide action: the josamycin and erythromycin cases.
    Lovmar M; Tenson T; Ehrenberg M
    J Biol Chem; 2004 Dec; 279(51):53506-15. PubMed ID: 15385552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the side effects and gastrointestinal motility observed after administration of erythromycin and josamycin to dogs.
    Qin XY; Pilot MA; Thompson HH; Maskell JP
    J Antimicrob Chemother; 1986 Dec; 18(6):747-56. PubMed ID: 3818498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo effects of josamycin, erythromycin, and placebo therapy on nasal carriage of Staphylococcus aureus.
    Wilson SZ; Martin RR; Putman M
    Antimicrob Agents Chemother; 1977 Mar; 11(3):407-10. PubMed ID: 324389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and saliva concentrations for a new formulation of erythromycin stearate.
    Berend N; Rutland J; Marlin GE
    Curr Med Res Opin; 1979; 6(2):118-23. PubMed ID: 467089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of josamycin and erythromycin in the therapy of Mycoplasma pneumoniae pneumonia.
    Wenzel RP; Hendley JO; Dodd WK; Gwaltney JM
    Antimicrob Agents Chemother; 1976 Dec; 10(6):899-901. PubMed ID: 795375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic interpretation of erythromycin and tylosin activity in serum after intravenous administration of a single dose to cows.
    Baggot JD; Gingerich DA
    Res Vet Sci; 1976 Nov; 21(3):318-23. PubMed ID: 1030820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics and tolerance of oral erythromycin stearate compared with erythromycin ethylsuccinate: implications for preventing endocarditis.
    Shanson DC; Tidbury P; McNabb WR; Tadayon M
    J Antimicrob Chemother; 1984 Aug; 14(2):157-63. PubMed ID: 6334070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative bioavailability of enteric coated pellets, stearate and ethylsuccinate formulations of erythromycin.
    Tjandramaga TB; Van Hecken A; Mullie A; Verbesselt R; De Schepper PJ; Verbist L; Josefsson K
    Pharmacology; 1984; 29(6):305-11. PubMed ID: 6334320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of josamycin with macrolides and related antibiotics on isolated rat atria.
    Tamargo J; De Miguel B; Tejerina MT
    Eur J Pharmacol; 1982 Jun; 80(4):285-93. PubMed ID: 7106186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of Josamycin in patients with liver cirrhosis and Gilbert's syndrome after repeated doses.
    Okolicsanyi L; Venuti M; Strazzabosco M; Biral A; Orlando R; Iemmolo RM; Nassuato G; Muraca M; Padrini G; Miglioli PA
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):434-8. PubMed ID: 4044077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new macrolide, TE-031 (A-56268), in treatment of experimental Legionnaires' disease.
    Kohno S; Koga H; Yamaguchi K; Masaki M; Inoue Y; Dotsu Y; Masuyama Y; Hayashi T; Hirota M; Saito A
    J Antimicrob Chemother; 1989 Sep; 24(3):397-405. PubMed ID: 2530201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotics excretion in canine vaginal and urethral secretions.
    Hoyme U; Baumueller A; Madsen PO
    Invest Urol; 1978 Jul; 16(1):35-8. PubMed ID: 29017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of rosaramicin and erythromycin stearate for treatment of cervical infection with Chlamydia trachomatis.
    Robson HG; Shah PP; Lalonde RG; Hayes L; Senikas VM
    Sex Transm Dis; 1983; 10(3):130-4. PubMed ID: 6648747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels following single and repeated doses of erythromycin estolate and erythromycin stearate.
    Welling PG; Elliott RL; Pitterle ME; Corrick-West HP; Lyons LL
    J Pharm Sci; 1979 Feb; 68(2):150-5. PubMed ID: 423080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic evaluation of orally administered antibiotics in infants and children: effect of feeding on bioavailability.
    McCracken GH; Ginsburg CM; Clahsen JC; Thomas ML
    Pediatrics; 1978 Nov; 62(5):738-43. PubMed ID: 581516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolide accumulation by Bacteroides fragilis ATCC 25285.
    Muto Y; Bandoh K; Watanabe K; Katoh N; Ueno K
    Antimicrob Agents Chemother; 1989 Feb; 33(2):242-4. PubMed ID: 2719467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.